Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
Research output
-
Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor microenvironment
Ertveldt, T., Krasniqi, A., Ceuppens, H., Puttemans, J., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., De Veirman, K., Morgenstern, A., Bruchertseifer, F., Keyaerts, M., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 27 Sep 2023.Research output: Unpublished contribution to conference › Poster
-
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α
Dekempeneer, Y., Massa, S., Santens, F., Navarro, L., Berdal, M., Miranda Lucero, M., Pombo Antunes, A. R., Lahoutte, T., Van Ginderachter, J. A., Devoogdt, N. & D'Huyvetter, M., Dec 2023, In: Journal of Nuclear Medicine. 64, 12, p. 1941-1948 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)16 Downloads (Pure) -
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
Ertveldt, T., Krasniqi, A., Ceuppens, H., Puttemans, J., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., De Veirman, K., Morgenstern, A., Bruchertseifer, F., Keyaerts, M., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 1 May 2023, In: Journal of Nuclear Medicine. 64, 5, p. 751-758 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile10 Citations (Scopus)28 Downloads (Pure) -
Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer
Rodak, M., Dekempeneer, Y., Wojewódzka, M., Caveliers, V., Covens, P., Miller, B. W., Sevenois, M. B., Bruchertseifer, F., Morgenstern, A., Lahoutte, T., D'Huyvetter, M. & Pruszynski, M., 1 Dec 2022, In: Molecular Cancer Therapeutics. 21, 12, p. 1835-1845 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Citations (Scopus)15 Downloads (Pure) -
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 Feb 2020, p. page 79. 1 p.Research output: Unpublished contribution to conference › Poster
Open AccessFile22 Downloads (Pure)
Prizes
-
INCOVO Price Cancer Research
Dekempeneer, Yana (Recipient), Dec 2016
Prize: Prize (including medals and awards)
-
Junior Travel Grant TAT 2017
Dekempeneer, Yana (Recipient), 30 Mar 2017
Prize: Prize (including medals and awards)
-
Travel Grant EANM 2017
Dekempeneer, Yana (Recipient), 22 Oct 2017
Prize: Prize (including medals and awards)
-
Travel Grant Research Stay Gothenburg
Dekempeneer, Yana (Recipient), 1 May 2016
Prize: Prize (including medals and awards)
Activities
-
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor) & Yana Dekempeneer (Contributor)
2020Activity: Other
-
Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation
Yana Dekempeneer (Speaker)
11 May 2019Activity: Talk or presentation › Talk or presentation at a conference
-
Combining bismuth-213 with Nanobodies: finding the match for Targeted Alpha Radionuclide Therapy
Yana Dekempeneer (Speaker)
1 Apr 2019 → 5 Apr 2019Activity: Talk or presentation › Talk or presentation at a conference
-
11th International Symposium on Targeted-Alpha-Therapy
Yana Dekempeneer (Participant)
1 Apr 2019 → 5 Apr 2019Activity: Participating in or organising an event › Participation in conference
-
European Molecular Imaging Meeting - EMIM 2018
Carlien Geldof (Organiser) & Yana Dekempeneer (Organiser)
21 Mar 2018Activity: Participating in or organising an event › Participation in conference
Press/Media
-
-
Q&A: Treating cancer with precisely targeted drugs
3/02/17
1 item of Media coverage
Press/Media: Research
-
-
Jonge wetenschapster krijgt beurs: Yana onderzoekt of kamelen kanker kunnen helpen bestrijden (Het Nieuwsblad)
28/11/15
1 item of Media coverage
Press/Media: Research
-
Incovo steunt baanbrekend kankeronderzoek van jonge, Zemstse wetenschapper
14/12/16
1 item of Media coverage
Press/Media: Research
Thesis
-
Radiolabeling of nanobodies with Bismuth-213 for Targeted Alpha Therapy
Author: Caveliers, V., Rens, L. & Dekempeneer, Y., 5 Sep 2019Student thesis: Master's Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Author: Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Cardinaels, T., Cornelissen, B., Flamen, P., Hernot, S., Ballet, S. & Breckpot, K., 2 Sep 2020Supervisor: Caveliers, V. (Promotor), D'Huyvetter, M. (Promotor), Cardinaels, T. (External person) (Co-promotor), Cornelissen, B. (External person) (Jury), Flamen, P. (Jury), Ballet, S. (Jury), Hernot, S. (Jury) & Breckpot, K. (Jury)
Student thesis: Doctoral Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Author: Ballet, S. & Dekempeneer, Y., Sep 2020Supervisor: Ballet, S. (Jury)
Student thesis: Doctoral Thesis
-
TARGETED ALPHA THERAPY WITH SINGLE-DOMAIN ANTIBODY FRAGMENTS, A NOVEL CANCER TREATMENT
Author: Ballet, S. & Dekempeneer, Y., Jun 2020Supervisor: Ballet, S. (Jury)
Student thesis: Doctoral Thesis
-
The therapeutic efficacy of bismuth-213 labeled anti-HER2 nanobodies in a preclinical model of ovarian cancer
Author: Cantoro, N., Caveliers, V. & Dekempeneer, Y., 12 Jun 2020Student thesis: Master's Thesis